Gamma Investing LLC Viridian Therapeutics, Inc.\De Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Gamma Investing LLC holds 8,425 shares of VRDN stock, worth $110,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,425
Previous 211
3892.89%
Holding current value
$110,620
Previous $4.05 Million
84.55%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VRDN
# of Institutions
199Shares Held
79.2MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$62.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$60.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$59.4 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$51 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$46.3 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $524M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...